4. Galenic formulation
In this section, we describe the use of microfluidic supports to obtain finished pharmaceutical products. These end products are innovative pharmaceutical formulations such as i) "soft phases" (e.g. liposomes or other lipid nanoparticles, micelles, vesicles, etc.), ii) solid particles (e.g. lipid particles or polymeric capsules), iii) or three-dimensional matrix networks called "microgels"
[J 8 010]
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!
Ongoing reading
Galenic formulation